semaglutide / tirzepatide vs. Semaglutide: Which is Best for Weight Loss? Addressing the Weight Loss Injectable

* Based on the average weight loss in three 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced- calorie diet and increased physical activity

May indicate measurement issues or other factors affecting response

This tirzepatide summary boils down to one truth: its a powerful tool, not a magic wand

Our peptide protocol guide covers restart strategies in detail

What is Tirzepatide?+ Tirzepatide (research code LY3298176) is a synthetic 39-amino-acid peptide engineered to act as a single-molecule dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor